about
Priorities among effective clinical preventive services: results of a systematic review and analysisPartnership research: a practical trial design for evaluation of a natural experiment to improve depression careEffect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trialDesigning and implementing research on a statewide quality improvement initiative: the DIAMOND study and initiative.Design and rationale for Home Blood Pressure Telemonitoring and Case Management to Control Hypertension (HyperLink): a cluster randomized trial.A stepped-wedge evaluation of an initiative to spread the collaborative care model for depression in primary careSmoking-attributable medical expenditures by age, sex, and smoking status estimated using a relative risk approachA Successful Multifaceted Trial to Improve Hypertension Control in Primary Care: Why Did it Work?Adherence to blood pressure telemonitoring in a cluster-randomized clinical trialCost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer.Repeated tobacco-use screening and intervention in clinical practice: health impact and cost effectiveness.Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.Colorectal cancer screening: health impact and cost effectiveness.Using Principles of Complex Adaptive Systems to Implement Secondary Prevention of Coronary Heart Disease in Primary Care.Primary care intervention to reduce alcohol misuse ranking its health impact and cost effectiveness.Updated Priorities Among Effective Clinical Preventive Services.Health Benefits and Cost-Effectiveness of Asymptomatic Screening for Hypertension and High Cholesterol and Aspirin Counseling for Primary Prevention.Health Benefits and Cost-Effectiveness of Brief Clinician Tobacco Counseling for Youth and Adults.A substudy evaluating treatment intensification on medication adherence among hypertensive patients receiving home blood pressure telemonitoring and pharmacist management.Modeled Health and Economic Impact of Team-Based Care for Hypertension.Patient characteristics associated with greater blood pressure control in a randomized trial of home blood pressure telemonitoring and pharmacist management.Greater use of preventive services in U.S. health care could save lives at little or no cost.Community-level incentives to increase the use of vaccination services in developing countries: an idea whose time has come?The association between health assessment-derived summary health scores and health care costs.Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.Births by day of week: a historical perspective.Economic Evaluation of the Home Blood Pressure Telemonitoring and Pharmacist Case Management to Control Hypertension (Hyperlink) TrialChanges in physical activity and short-term changes in health care charges: a prospective cohort study of older adultsProactive recruitment of health plan smokers into telephone counselingSelf-reported hypertension treatment beliefs and practices of primary care physicians in a managed care organizationUse and costs of care in retail clinics versus traditional care sitesModeling the Health and Budgetary Impacts of a Team-based Hypertension Care Intervention That Includes PharmacistsThe 20-year impact of tobacco price and tobacco control expenditure increases in Minnesota, 1998-2017Projecting the future impact of past accomplishments in tobacco controlTwenty-year health and economic impact of reducing cigarette use: Minnesota 1998-2017Budgetary impact from multiple perspectives of sustained antitobacco national media campaigns to reduce the harms of cigarette smokingLong-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial
P50
Q28219137-D471DAD3-F30A-4A1F-958F-592AC967AEF9Q28649536-7B99D595-C776-419F-BD33-719639FC0922Q35031598-17736885-8A94-4442-9A65-330E8F030B53Q35990207-E8EF8624-E5F7-49B6-A474-1CEAEC62891DQ35992372-4249019B-1663-4790-B1C5-2048D1F9AE22Q36058627-8D5F1F90-89CE-4F03-939A-5641A0C11A8AQ36136133-602C0A3C-24DE-4907-AC9E-0221423BA205Q36199397-8ADBE10E-FB89-44B1-A578-6EB8CD9FB531Q36299643-36B3D833-CBB3-4249-A6F7-5D861F015111Q36444723-93F68E2D-A2F5-43E2-A7A6-D2906D44957BQ36507900-72984F1D-09E1-405D-9B4F-C4B515066DAAQ36507905-DD68B0EE-2BE4-43C0-8CDE-16AD59455C6EQ36507909-38D0F791-279E-49AC-96D5-FE90D6FC119DQ36903552-9C414D05-2061-45BE-9795-879D483972D5Q37059304-C5EC3271-9610-49AE-A090-74D6E46202BEQ37567485-3EAAEDEA-66E0-4B83-96FB-93CA58314902Q37567490-93F0E346-37DB-4DA7-930A-3E10AC0FD625Q37567494-48EF7493-5648-4046-82C7-19DC190044E6Q39641845-BD398B80-8586-41FB-86B4-B9F188F86857Q39832076-56CFE278-8874-4550-90B4-C97ABB82DB43Q42742751-DABD2739-B47A-4162-9539-4B1079C8B094Q42916264-68CADA00-452C-47F2-A84A-3597A8B9B24AQ48194907-E3DD015E-E632-40B3-95F9-64132E193C54Q48626551-AC448FEE-EF5B-429E-8A97-1AD072F77459Q53125840-96CB79D0-FABE-462B-B0F8-7FCCA07AC424Q53313222-342F6775-5CC4-4F36-A259-6F1561471D4AQ57487374-2048A1F2-2096-470C-906B-DBEC9117385AQ79079990-01CBCD51-0D8D-4492-B99E-36EA7155BE4AQ80206304-D4C7254B-BFC4-4E94-AADE-297776653846Q81651974-45597D17-1E31-4D4B-B245-3C6954425E17Q81945736-B248F1C0-6091-440D-A327-4B316F02DB97Q90371616-1B412A6E-62E7-4A87-9240-474065E69F0DQ90427237-96036737-1E5E-4A60-9046-D440AA34665AQ90468790-E7FDFD0F-2C6F-4B8E-BBC4-8038FB6C0036Q92623478-28A004CF-C5F8-4EE8-811A-AF347FF1AE92Q93268735-71E7823E-51E9-4435-AF34-8F6B9BBE3DA5Q93472100-C1E061FC-30F3-487A-B149-BD74C9C6DBC9
P50
description
Forscher
@de
investigador
@es
onderzoeker
@nl
researcher
@en
ricercatore
@it
研究員
@ja
研究者
@zh
name
Michael V Maciosek
@en
Michael V Maciosek
@nl
type
label
Michael V Maciosek
@en
Michael V Maciosek
@nl
prefLabel
Michael V Maciosek
@en
Michael V Maciosek
@nl
P106
P31
P496
0000-0002-8164-8858